Histone deacetylase inhibitors: insights into mechanisms of lethality

RR Rosato, S Grant - Expert opinion on therapeutic targets, 2005 - Taylor & Francis
Histone deacetylases (HDACs) have recently emerged as an important target for therapeutic
intervention in cancer and potentially other human diseases. By modulating the acetylation …

Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors

XY Pei, Y Dai, S Grant - Clinical Cancer Research, 2004 - AACR
Purpose: The purpose of this study was to examine interactions between the proteasome
inhibitor bortezomib (Velcade) and the histone deacetylase (HDAC) inhibitors sodium …

Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity

A Nencioni, J Beck, D Werth, F Grünebach… - Clinical Cancer …, 2007 - AACR
Purpose: Histone deacetylases (HDAC) modulate gene transcription and chromatin
assembly by modifying histones at the posttranscriptional level. HDAC inhibitors have …

HDAC3 selectively represses CREB3-mediated transcription and migration of metastatic breast cancer cells

HC Kim, KC Choi, HK Choi, HB Kang, MJ Kim… - Cellular and molecular …, 2010 - Springer
We identified CREB3 as a novel HDAC3-interacting protein in a yeast two-hybrid screen for
HDAC3-interacting proteins. Among all class I HDACs, CREB3 specifically interacts with …

Mannose‐Decorated Co‐Polymer Facilitates Controlled Release of Butyrate to Accelerate Chronic Wound Healing

AL Lauterbach, AJ Slezak, R Wang… - Advanced …, 2023 - Wiley Online Library
Butyrate is a key bacterial metabolite that plays an important and complex role in modulation
of immunity and maintenance of epithelial barriers. Its translation to clinic is limited by poor …

[HTML][HTML] Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma …

V Baradari, M Höpfner, A Huether… - World journal of …, 2007 - ncbi.nlm.nih.gov
AIM: To investigate the antiproliferative effect of the histone deacetylase (HDAC) inhibitor
MS-275 on cholangiocarcinoma cells alone and in combination with conventional cytostatic …

Sequence-dependent interaction between cisplatin and histone deacetylase inhibitors in human oral squamous cell carcinoma cells

T Sato, M Suzuki, Y Sato… - … journal of oncology, 2006 - spandidos-publications.com
Chemotherapeutic treatment with combinations of drugs is front-line therapy for many types
of cancer. Combining drugs that target different signaling pathways often lessens adverse …

Oligomeric proanthocyanidins attenuate airway inflammation in asthma by inhibiting dendritic cells maturation

Y Li, Q Yu, W Zhao, J Zhang, W Liu, M Huang… - Molecular …, 2017 - Elsevier
To date, although a promising anti-inflammatory activity of oligomeric proanthocyanidins
(OPCs) has been observed in asthma, the mechanism responsible for these …

Induction of cell signaling events by the cholera toxin B subunit in antigen-presenting cells

AC Schnitzler, JM Burke, LM Wetzler - Infection and immunity, 2007 - Am Soc Microbiol
Cholera toxin (CT) is one of the most effective and widely studied mucosal adjuvants.
Although the ADP-ribosylating A subunit has been implicated in augmenting immune …

LIGHT regulates CD86 expression on dendritic cells through NF‐κB, but not JNK/AP‐1 signal transduction pathway

GM Zou, WY Hu - Journal of cellular physiology, 2005 - Wiley Online Library
The members of the tumor necrosis factor (TNF) family play pivotal roles in the regulation of
the immune system. LIGHT is a type II transmembrane protein belonging to the TNF family …